Enzon Pharmaceuticals Inc (ENZN)
0.0795
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Enzon Pharmaceuticals Max Drawdown (5Y): 92.81% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.81% |
| September 30, 2024 | 92.81% |
| August 31, 2024 | 92.81% |
| July 31, 2024 | 92.81% |
| June 30, 2024 | 92.81% |
| May 31, 2024 | 92.81% |
| April 30, 2024 | 92.81% |
| March 31, 2024 | 92.81% |
| February 29, 2024 | 92.18% |
| January 31, 2024 | 89.82% |
| December 31, 2023 | 89.80% |
| November 30, 2023 | 88.91% |
| October 31, 2023 | 85.63% |
| September 30, 2023 | 85.63% |
| August 31, 2023 | 85.63% |
| July 31, 2023 | 85.63% |
| June 30, 2023 | 85.63% |
| May 31, 2023 | 85.63% |
| April 30, 2023 | 76.32% |
| March 31, 2023 | 76.32% |
| February 28, 2023 | 76.32% |
| January 31, 2023 | 76.32% |
| December 31, 2022 | 76.32% |
| November 30, 2022 | 76.32% |
| October 31, 2022 | 76.32% |
| Date | Value |
|---|---|
| September 30, 2022 | 76.32% |
| August 31, 2022 | 76.32% |
| July 31, 2022 | 76.32% |
| June 30, 2022 | 76.32% |
| May 31, 2022 | 76.32% |
| April 30, 2022 | 76.32% |
| March 31, 2022 | 76.32% |
| February 28, 2022 | 76.32% |
| January 31, 2022 | 76.32% |
| December 31, 2021 | 76.32% |
| November 30, 2021 | 76.32% |
| October 31, 2021 | 76.32% |
| September 30, 2021 | 76.32% |
| August 31, 2021 | 76.32% |
| July 31, 2021 | 76.32% |
| June 30, 2021 | 76.32% |
| May 31, 2021 | 76.32% |
| April 30, 2021 | 76.32% |
| March 31, 2021 | 76.32% |
| February 28, 2021 | 76.32% |
| January 31, 2021 | 76.32% |
| December 31, 2020 | 76.32% |
| November 30, 2020 | 76.32% |
| October 31, 2020 | 76.32% |
| September 30, 2020 | 76.32% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
76.32%
Minimum
Nov 2019
92.81%
Maximum
Mar 2024
80.37%
Average
76.32%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| AIM ImmunoTech Inc | 99.61% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Electromed Inc | 55.84% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.79 |
| Beta (5Y) | 0.5349 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.00% |
| Historical Sharpe Ratio (5Y) | -0.2185 |
| Historical Sortino (5Y) | -0.6259 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.09% |